Journal name: World Journal of Pharmaceutical Research
Original article title: Taxol production using microbes
The WJPR includes peer-reviewed publications such as scientific research papers, reports, review articles, company news, thesis reports and case studies in areas of Biology, Pharmaceutical industries and Chemical technology while incorporating ancient fields of knowledge such combining Ayurveda with scientific data.
This page presents a generated summary with additional references; See source (below) for actual content.
Subtitle: a review
Original source:
This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.
Harshitha V., Krithika K., Mohan P., Zeeba Naaz S., S. Narendra Kumar, Dr. Ajeet Kumar Srivastava and Dr. Lingayya Hiremath
Download the PDF file of the original publication
World Journal of Pharmaceutical Research:
(An ISO 9001:2015 Certified International Journal)
Full text available for: Taxol production using microbes
Source type: An International Peer Reviewed Journal for Pharmaceutical and Medical and Scientific Research
Doi: 10.20959/wjpr202314-29209
Copyright (license): WJPR: All rights reserved
Summary of article contents:
Introduction
Taxol, also known as paclitaxel, is a widely used and highly effective anticancer drug originally derived from the bark of the Pacific yew tree (Taxus brevifolia). Due to environmental concerns and the scarcity of this natural source, researchers have been exploring alternative methods for taxol production. This review discusses the potential of microbial biotechnology as a sustainable and cost-effective approach for producing taxol, examining the various microbes involved, the processes used in biosynthesis, and current advancements in the field aimed at increasing yields.
Microbial Production of Taxol: A Sustainable Approach
Microbial biotechnology has emerged as an important method for producing taxol, leveraging genetically modified microorganisms, such as bacteria and fungi, to enhance production efficiencies. By introducing taxol biosynthetic genes into microbial systems, researchers have the potential to overcome the limitations of traditional extraction methods. Though historically, fungi have been the primary source of taxol, efforts are increasingly focused on bacteria due to their faster growth rates and the flexibility of genetic manipulation. Genetic engineering techniques are employed to optimize metabolic pathways associated with taxol production, enabling more effective biosynthesis in microbial hosts.
The Taxol Biosynthetic Pathway
The biosynthetic pathway for taxol production in microbes involves several enzymatic processes that convert precursor molecules into the final compound. Initial isoprenoid substrates required for biosynthesis can be derived from either the mevalonate (MVA) or methylerythritol phosphate (MEP) pathways. Bacterial hosts often utilize the MEP pathway, which is critical for generating the building blocks that lead to taxadiene—the precursor to taxol. Subsequent enzymatic reactions, facilitated by specific gene products, create taxadiene and further modify it through oxidation and acylation steps, eventually leading to the formation of taxol.
Advances in Taxol Production
Significant advancements have been made in the engineering of microbial systems for taxol production. Researchers are now focusing on designing synthetic gene circuits and optimizing metabolic pathways, alongside heterologous expression of the complete taxol biosynthetic route in easier-to-cultivate microbes like E. coli and S. cerevisiae. Improvement in process control and production yields can be achieved through better fermentation techniques, enabling more efficient cultivation conditions and recovery processes, such as chromatography and solvent extraction, which are crucial for isolating taxol from microbial cultures.
Conclusion
The ongoing research into microbial production of taxol has revealed several promising avenues for making this life-saving anticancer drug more accessible. Current yields from genetically modified bacterial species range from 1% to 2.5%, which is superior to traditional extraction methods. Moving forward, future strategies will aim to refine the entire taxol biosynthetic pathway, focusing on metabolic engineering and innovative process development. By optimizing these approaches, the potential for large-scale, cost-effective production of taxol can be realized, paving the way for broad accessibility and differentiation in the chemical structure of anticancer agents.
FAQ section (important questions/answers):
What is Taxol and what is its significance in cancer treatment?
Taxol, also known as paclitaxel, is a powerful anticancer drug that significantly alters cancer treatment by preventing cancer cells from dividing normally. It was originally derived from the Pacific yew tree but is now sought to be produced through more sustainable methods.
How is Taxol traditionally produced before microbial methods were explored?
Traditionally, Taxol was extracted from the bark of the Pacific yew tree, which is limited in availability and has raised environmental concerns, leading to the need for alternative production methods.
What role does microbial biotechnology play in Taxol production?
Microbial biotechnology utilizes genetically modified microorganisms to produce Taxol through biosynthetic pathways, aiming to offer sustainable, affordable, and efficient alternatives to traditional extraction methods.
Which microbes are involved in the production of Taxol?
Fungi such as Taxomyces andreanae and Pestalotiopsis microspora, as well as bacteria like Streptomyces and Burkholderia species, are known to produce Taxol either naturally or through genetic modification.
How does the biosynthesis of Taxol occur in bacteria?
In bacteria, Taxol biosynthesis involves enzymatic processes that convert precursor molecules into Taxol. Key steps include using the MEP pathway for isoprenoid production, followed by various enzymatic transformations to yield Taxol.
What challenges remain in the microbial production of Taxol?
Despite advances, challenges such as optimizing yields, reducing production costs, and developing efficient purification methods continue to be important for making microbial Taxol production economically viable.
Glossary definitions and references:
Scientific and Ayurvedic Glossary list for “Taxol production using microbes”. This list explains important keywords that occur in this article and links it to the glossary for a better understanding of that concept in the context of Ayurveda and other topics.
1) Kumar:
Kumar refers to one of the authors involved in the study on taxol production using microbes. His collaboration with other researchers, such as Dr. S. Narendra Kumar and Dr. Ajeet Kumar Srivastava, highlights the contribution of academic professionals in exploring innovative methods for producing important pharmaceutical compounds like paclitaxel, emphasizing collective research efforts in biotechnology.
2) Cancer:
Cancer is a significant focus of the study as taxol (paclitaxel) serves as an effective treatment for various types of cancer. Understanding cancer's impact on individuals and society emphasizes the importance of developing accessible and affordable treatments. The research aims to enhance taxol production to improve therapeutic options for cancer patients globally.
3) Species:
Species denotes the different types of microorganisms investigated for their capacity to produce taxol. This includes bacteria and fungi like Taxomyces and Pestalotiopsis. Understanding the diversity of these species is crucial for identifying potential sources of paclitaxel and optimizing biotechnological methods for sustainable and large-scale production.
4) Tree:
Trees, in this context, highlight the initial source of taxol, the Pacific yew, emphasizing issues related to the sustainable harvest of natural resources. The research aims to reduce dependency on tree-derived sources through microbial production, thereby addressing ecological concerns while maintaining or increasing the supply of this vital pharmaceutical compound.
5) India:
India is the geographical context of the research, specifically referencing the R. V. College of Engineering, where the study took place. Highlighting this location underscores the role of Indian institutions in advancing biopharmaceutical research and their contribution to addressing global health challenges through innovative approaches in the life sciences.
6) Transformation (Transform, Transforming):
Transform indicates the genetic engineering process that alters the metabolic pathways of microorganisms to enable them to produce taxol. This transformation is vital for increasing production efficiency and optimizing yields. The study focuses on enhancements through metabolic engineering, facilitating innovation in the pharmaceutical production of paclitaxel.
7) Narendra (Nara-indra):
Narendra is referenced as one of the corresponding authors of the study. His role indicates the involvement of knowledgeable academic professionals in guiding research initiatives aimed at optimizing taxol production using microbes. Such leadership is pivotal in bridging the gap between scientific inquiry and practical applications in medicine.
8) Activity:
Activity pertains to the enzymatic processes involved in the biosynthesis of taxol. Understanding the activity of specific enzymes is crucial for engineering microbes to enhance taxol production, which is a central goal of the research. This knowledge enables targeted improvements in the metabolic pathways utilized by the microbes.
9) Study (Studying):
Study refers to the systematic investigation conducted to review and analyze the microbial production of taxol. It serves as a critical foundation for understanding current advancements and future directions in the field of microbial biotechnology, emphasizing the importance of research in developing effective treatments for cancer and improving drug accessibility.
10) Purification:
Purification refers to the processes involved in isolating taxol from microbial cultures after production. It is a crucial step in ensuring the quality and efficacy of the final product. Advanced purification techniques, necessary for removing impurities and unwanted byproducts, are integral to the successful commercialization of taxol produced by engineered microbes.
11) Srivastava (Sri-vastava, Shrivastava, Shri-vastava):
Srivastava denotes Dr. Ajeet Kumar Srivastava, one of the authors contributing expertise to the study. His involvement illustrates the collaborative effort among researchers for advancements in biopharmaceuticals through research on microbial production of taxol, showcasing the integration of academic knowledge and practical applications in cancer treatment.
12) Similarity:
Similarity relates to the comparison of genetic sequences involved in taxol production across different species. Such analyses aid in understanding evolutionary relationships and the potential for engineering microbes to enhance taxol biosynthesis. Establishing similarity among genetic sequences can facilitate the development of more effective and efficient production processes.
13) Dividing:
Dividing refers to the process of cell division that is inhibited by taxol, leading to its antitumor properties. Taxol's ability to stabilize microtubules prevents the normal cycle of cell division in cancer cells, inducing apoptosis. This characteristic is crucial for understanding the therapeutic mechanisms of taxol in treating various cancers.
14) Cutting:
Cutting in this context may refer to cutting-edge techniques and methodologies applied in microbial biotechnology for paclitaxel production. It emphasizes the innovative approaches taken in genetic engineering and metabolic optimization to enhance taxol yields. Such advancements are essential for progressing the production methods to meet increasing medical demands.
15) Death:
Death pertains to the ultimate outcome of apoptosis induced by taxol in cancer cells. Understanding the mechanism by which taxol triggers cell death is critical for appreciating its effectiveness as an anticancer agent. The study underscores the importance of developing drugs that exploit these mechanisms to effectively combat cancer.
16) Trina (Tri-na, Trna):
tRNA (transfer RNA) plays a role in the protein synthesis pathways present in the microbial hosts utilized for taxol production. Though not explicitly detailed in the study, understanding the function of tRNA is important for genetic engineering efforts, where the proper translation of engineered genes into proteins is crucial for biosynthetic efficiency.
17) Rich (Rch):
Rich refers to the nutrient-rich media used for cultivating genetically modified microorganisms in bioreactors during taxol production. Optimizing the composition of growth media is essential to enhance microbial growth and metabolic activity, ultimately aiming for higher yields of paclitaxel production from engineered strains.
18) Wall:
Wall signifies the cell wall structure of microorganisms, which can influence their ability to produce taxol. Understanding the composition and integrity of microbial cell walls is important for optimizing genetic transformation processes, facilitating efficient production of taxol, and ensuring stability in engineered strains during fermentation processes.
19) Drug:
Drug highlights the importance of taxol as a critical pharmaceutical compound used in cancer treatment. Understanding drug production through sustainable methods is a primary goal of the study, which aims to provide increased access to effective medications. Focusing on microbial biotechnological approaches addresses both drug efficacy and availability issues.
20) Life:
Life in this context underscores the significance of taxol in extending the lives of cancer patients, emphasizing the urgent need for effective cancer treatments. The research aims to enhance taxol production through biotechnology, which may improve patient outcomes and provide better access to life-saving medications across different regions.
Other Science Concepts:
Discover the significance of concepts within the article: ‘Taxol production using microbes’. Further sources in the context of Science might help you critically compare this page with similair documents:
Apoptosis, Cancer treatment, Biochemical processes, Cell division, Anticancer drug, Production yield, Chromatography technique, Biosynthetic pathway, Microbial biotechnology, Enzymatic processes, Effective techniques, Genetically modified microorganisms, MITOTIC ARREST, MITOTIC CHECKPOINT, Sustainable technique, Metabolic engineering, Industrial engineering.